1.
Long J, Xie S, Zhang W, Dou W, Wang Y, Wang R, Liu H, Xu Z. The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy. Haematologica 2025;110(6):1412-1416; https://doi.org/10.3324/haematol.2024.286689.